AU2002229109A1 - Methods for diagnosing and treating pediatric neoplasms - Google Patents

Methods for diagnosing and treating pediatric neoplasms

Info

Publication number
AU2002229109A1
AU2002229109A1 AU2002229109A AU2910902A AU2002229109A1 AU 2002229109 A1 AU2002229109 A1 AU 2002229109A1 AU 2002229109 A AU2002229109 A AU 2002229109A AU 2910902 A AU2910902 A AU 2910902A AU 2002229109 A1 AU2002229109 A1 AU 2002229109A1
Authority
AU
Australia
Prior art keywords
diagnosing
methods
treating pediatric
pediatric neoplasms
neoplasms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002229109A
Inventor
Antonio Iavarone
Anna Lasorella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Albert Einstein College of Medicine
Original Assignee
Albert Einstein College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert Einstein College of Medicine filed Critical Albert Einstein College of Medicine
Publication of AU2002229109A1 publication Critical patent/AU2002229109A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002229109A 2000-12-21 2001-12-19 Methods for diagnosing and treating pediatric neoplasms Abandoned AU2002229109A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25784700P 2000-12-21 2000-12-21
US60/257,847 2000-12-21
PCT/US2001/049163 WO2002049502A2 (en) 2000-12-21 2001-12-19 Methods for diagnosing and treating pediatric neoplasms

Publications (1)

Publication Number Publication Date
AU2002229109A1 true AU2002229109A1 (en) 2002-07-01

Family

ID=22978019

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002229109A Abandoned AU2002229109A1 (en) 2000-12-21 2001-12-19 Methods for diagnosing and treating pediatric neoplasms

Country Status (5)

Country Link
US (2) US20030003467A1 (en)
EP (1) EP1356078A4 (en)
AU (1) AU2002229109A1 (en)
CA (1) CA2432682A1 (en)
WO (1) WO2002049502A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4032434B2 (en) * 1992-11-13 2008-01-16 住友電気工業株式会社 Human Id gene
US6127178A (en) * 1998-03-20 2000-10-03 The Regents Of The University Of California Apoptotic peptides
US20020151681A1 (en) * 1999-03-12 2002-10-17 Rosen Craig A. Nucleic acids, proteins and antibodies

Also Published As

Publication number Publication date
US20030003467A1 (en) 2003-01-02
US7816089B2 (en) 2010-10-19
EP1356078A2 (en) 2003-10-29
WO2002049502A2 (en) 2002-06-27
CA2432682A1 (en) 2002-06-27
WO2002049502A3 (en) 2002-08-15
US20060121494A1 (en) 2006-06-08
EP1356078A4 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
AU2373200A (en) Apparatuses and methods for forming assemblies
AU2001268331A1 (en) Methods for diagnosing and treating thalamocortical dysrhythmia
AU2001275441A1 (en) Filter arrangement and methods
HK1051010A1 (en) Filter arrangement and methods
AU2001264771A1 (en) Well reference apparatus and method
EP1355715A4 (en) Filter apparatus and methods
EP1223932A4 (en) Compounds and methods
EP1146790A4 (en) Compounds and methods
AU3309300A (en) Hair treatment device and method
AU2031700A (en) Stereotactic apparatus and methods
AU2001284865A1 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
AU2001227224A1 (en) Tomographic apparatus and method
AU2001253391A1 (en) Filtering device and method
AU2001269947A1 (en) Noise reduction method and apparatus
AU1594701A (en) Stereotactic apparatus and methods
AU2001262978A1 (en) Method and apparatus for interference reduction
AU6145100A (en) Method and device for decontaminating polycondensates
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
AU2001289123A1 (en) Compounds and methods for diagnosing and treating amyloid-related conditions
AU7119100A (en) Stereotactic apparatus and methods
AU4395099A (en) Exposure method and device
AUPP828699A0 (en) Drying apparatus and methods
AU2001285172A1 (en) Enhanced electro-deposition device and method
AU2001285282A1 (en) Imaging device and method
AU2001218024A1 (en) Methods for treating and preventing alopecia

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application